Skip to content

Clinical trials

Observational Lung Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Observational Country / region: Italy Clear all

87 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20061
20081
20092
20102
20112
20122
20134
20143
20154
20162
20172
20184
20196
20208
20214
20228
202311
20246
20257
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Recruiting26
Unknown status19
Terminated3
Not yet recruiting2
Enrolling by invitation2
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Institute of Oncology10
Fondazione Policlinico Universitario Agostino Gemelli IRCCS5
University of Milan5
IRCCS Azienda Ospedaliero-Universitaria di Bologna4
Istituto Clinico Humanitas4
AstraZeneca3
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano3
Fondazione IRCCS Policlinico San Matteo di Pavia3
Maggiore Bellaria Hospital, Bologna3
Scientific Institute San Raffaele3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms87
Carcinoma, Non-Small-Cell Lung14
Breast Neoplasms9
Neoplasms9
Pulmonary Disease, Chronic Obstructive6
Urinary Bladder Neoplasms6
Melanoma5
Colorectal Neoplasms4
Head and Neck Neoplasms4
Neoplastic Cells, Circulating4

Trials

Showing 1 to 25 of 87. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.